• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gastroduodenal and intestinal permeability in primary biliary cirrhosis.

作者信息

Di Leo Vincenza, Venturi Carla, Baragiotta Anna, Martines Diego, Floreani Annarosa

机构信息

Department of Surgical and Gastroenterological Sciences, University of Padova, Italy.

出版信息

Eur J Gastroenterol Hepatol. 2003 Sep;15(9):967-73. doi: 10.1097/00042737-200309000-00005.

DOI:10.1097/00042737-200309000-00005
PMID:12923368
Abstract

OBJECTIVES

To evaluate gastrointestinal permeability in primary biliary cirrhosis (PBC), using a sensitive method to detect epithelial damage, and to correlate it with the Mayo score, histological stage, ascites, spontaneous bacterial peritonitis, endoscopic signs of portal hypertension and Helicobacter pylori infection.

METHODS

Fifty consecutive patients with PBC and 39 patients with cirrhosis of other aetiologies (non-PBC) were enrolled in the study. Coeliac disease was initially ruled out in all participants. Permeability was assessed using sucrose (gastro-duodenum) and lactulose-mannitol (intestine).

RESULTS

Sucrose excretion was above the limit in both PBC and non-PBC patients. Twenty-two per cent of PBC patients had an increased result for the lactulose-mannitol test compared to 12.8% of non-PBC cirrhotic patients. PBC patients had high sucrose excretion levels irrespective of the presence of any oesophageal varices, which significantly increased the gastroduodenal permeability in non-PBC patients only when associated with hypertensive gastropathy. Sucrose excretion was significantly enhanced by hypertensive gastropathy in non-PBC patients (P < 0.001) but not in PBC patients. No significant correlation was found in either group between gastrointestinal permeability and the other parameters.

CONCLUSIONS

Gastrointestinal permeability is increased in PBC. Portal hypertension contributes to altered gastric mucosal permeability in non-PBC cirrhosis, whereas different epithelial dysfunction can be hypothesized in PBC.

摘要

相似文献

1
Gastroduodenal and intestinal permeability in primary biliary cirrhosis.
Eur J Gastroenterol Hepatol. 2003 Sep;15(9):967-73. doi: 10.1097/00042737-200309000-00005.
2
Abnormal intestinal permeability in primary biliary cirrhosis.原发性胆汁性肝硬化患者的肠道通透性异常。
Dig Dis Sci. 2006 Sep;51(9):1607-13. doi: 10.1007/s10620-006-9544-z. Epub 2006 Aug 26.
3
Increased intestinal permeability in malnourished patients with liver cirrhosis.肝硬化营养不良患者的肠道通透性增加。
Eur J Clin Nutr. 2012 Oct;66(10):1116-9. doi: 10.1038/ejcn.2012.104. Epub 2012 Aug 8.
4
Gastric permeability to sucrose is increased in portal hypertensive gastropathy.门静脉高压性胃病中胃对蔗糖的通透性增加。
Eur J Gastroenterol Hepatol. 2000 May;12(5):529-33. doi: 10.1097/00042737-200012050-00009.
5
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.非选择性β受体阻滞剂治疗可降低肝硬化患者的肠通透性和血清 LBP、IL-6 水平。
J Hepatol. 2013 May;58(5):911-21. doi: 10.1016/j.jhep.2012.12.011. Epub 2012 Dec 20.
6
Gastroduodenal permeability in Crohn's disease.克罗恩病中的胃十二指肠通透性
Eur J Clin Invest. 1998 Jan;28(1):67-71. doi: 10.1046/j.1365-2362.1998.00241.x.
7
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.酒精性肝硬化中的肠屏障功能障碍:酒精性肝损伤的一种可能机制。
Am J Gastroenterol. 1999 Jan;94(1):200-7. doi: 10.1111/j.1572-0241.1999.00797.x.
8
Gastroduodenal, intestinal and colonic permeability during anticancer therapy.
Hepatogastroenterology. 2011 Jul-Aug;58(109):1193-9. doi: 10.5754/hge08101.
9
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.原发性胆汁性肝硬化中的慢性萎缩性胃炎和幽门螺杆菌感染:一项匹配的横断面研究
Ital J Gastroenterol Hepatol. 1997 Feb;29(1):13-7.
10
Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability.慢性荨麻疹中的假性过敏反应与胃十二指肠通透性改变有关。
Allergy. 2004 Oct;59(10):1118-23. doi: 10.1111/j.1398-9995.2004.00631.x.

引用本文的文献

1
Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis.可溶性疱疹病毒进入介质及II型/III型干扰素在原发性胆汁性胆管炎中上调。
Int J Mol Sci. 2025 Jan 13;26(2):605. doi: 10.3390/ijms26020605.
2
Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside.以肠道微生物群为靶点治疗原发性胆汁性胆管炎:从实验台到临床应用
J Clin Transl Hepatol. 2023 Aug 28;11(4):958-966. doi: 10.14218/JCTH.2022.00408. Epub 2023 Mar 1.
3
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy.
肠-肝免疫交通:解析免疫发病机制以支持转化治疗。
Front Immunol. 2021 Aug 25;12:711217. doi: 10.3389/fimmu.2021.711217. eCollection 2021.
4
The Gut-Liver Axis in Cholestatic Liver Diseases.胆汁淤积性肝病中的肠-肝轴。
Nutrients. 2021 Mar 21;13(3):1018. doi: 10.3390/nu13031018.
5
Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.肠道微生物群-巨噬细胞相互作用通过促进小鼠肠道通透性导致胆汁淤积性肝病。
Hepatology. 2020 Dec;72(6):2090-2108. doi: 10.1002/hep.31228.
6
Gut-liver axis signaling in portal hypertension.门脉高压症中的肠道-肝脏轴信号。
World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897.
7
To screen or not to screen? Celiac antibodies in liver diseases.筛查还是不筛查?肝脏疾病中的乳糜泻抗体。
World J Gastroenterol. 2017 Feb 7;23(5):776-791. doi: 10.3748/wjg.v23.i5.776.
8
Intestinal permeability in a patient with liver cirrhosis.肝硬化患者的肠道通透性
Ther Clin Risk Manag. 2016 Nov 18;12:1729-1748. doi: 10.2147/TCRM.S115902. eCollection 2016.
9
Primary biliary cirrhosis is a generalized autoimmune epithelitis.原发性胆汁性肝硬化是一种全身性自身免疫性上皮炎。
Int J Mol Sci. 2015 Mar 20;16(3):6432-46. doi: 10.3390/ijms16036432.
10
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study.肝硬化和门静脉高压症患者的小肠转运:描述性研究。
BMC Gastroenterol. 2012 Dec 8;12:176. doi: 10.1186/1471-230X-12-176.